Inventory of the Historical Archives of the Congregation for the Evangelization of Peoples or «De Propaganda Fide» (Studia Urbaniana, 33) N. Kowalsky J. Metzler

Autor: Wicki, Josef

Publikováno v: Gregorianum, 1991 Jan 01. 72(4), 804-805.

Externí odkaz: https://www.jstor.org/stable/23579149

Investigation of the current collapse behaviour in GaN power HEMTs with highly adjustable pulse and measurement concept

Autor: Goller, M., Thim, M.A., Song, J., Kowalsky, J., Franke, J., Lutz, J.

Publikováno v: In Microelectronics Reliability November 2020 114

Investigation of the avalanche ruggedness of SiC MPS diodes under repetitive unclamped-inductive-switching stress

Autor: Palanisamy, S., Ahmmed, Md.K., Kowalsky, J., Lutz, J., Basler, T.

Publikováno v: In Microelectronics Reliability September 2019 100-101

Intestinal microbiota controls graft-versus-host disease independent of donor-host genetic disparity.

Autor: Koyama M; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center (FHCC), Seattle, WA 98109, USA. Electronic address: mkoyama@fredhutch.org., Hippe DS; Clinical Research Division, FHCC, Seattle, WA 98109, USA., Srinivasan S; Vaccine and Infectious Disease Division, FHCC, Seattle, WA 98109, USA., Proll SC; Vaccine and Infectious Disease Division, FHCC, Seattle, WA 98109, USA., Miltiadous O; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Li N; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center (FHCC), Seattle, WA 98109, USA., Zhang P; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center (FHCC), Seattle, WA 98109, USA., Ensbey KS; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center (FHCC), Seattle, WA 98109, USA., Hoffman NG; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA 98195, USA., Schmidt CR; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center (FHCC), Seattle, WA 98109, USA., Yeh AC; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center (FHCC), Seattle, WA 98109, USA; Department of Medicine, University of Washington, Seattle, WA 98109, USA., Minnie SA; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center (FHCC), Seattle, WA 98109, USA., Strenk SM; Vaccine and Infectious Disease Division, FHCC, Seattle, WA 98109, USA., Fiedler TL; Vaccine and Infectious Disease Division, FHCC, Seattle, WA 98109, USA., Hattangady N; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center (FHCC), Seattle, WA 98109, USA., Kowalsky J; Vaccine and Infectious Disease Division, FHCC, Seattle, WA 98109, USA., Grady WM; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center (FHCC), Seattle, WA 98109, USA; Department of Medicine, University of Washington, Seattle, WA 98109, USA., Degli-Esposti MA; Infection and Immunity Program and Department of Microbiology, Biomedicine Discovery Institute, Monash University, Clayton, VIC 3800, Australia; Centre for Experimental Immunology, Lions Eye Institute, Nedlands, WA 6009, Australia., Varelias A; Transplantation Immunology Laboratory, Cancer Research Program, QIMR Berghofer Medical Research Institute, Brisbane, QLD 4006, Australia; Faculty of Medicine, University of Queensland, St Lucia, QLD 4067, Australia., Clouston AD; Molecular and Cellular Pathology, University of Queensland, Brisbane, QLD 4006, Australia., van den Brink MRM; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Weill Cornell Medical College, New York, NY 10065, USA; Department of Immunology, Sloan Kettering Institute, New York, NY 10065, USA., Dey N; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center (FHCC), Seattle, WA 98109, USA; Department of Medicine, University of Washington, Seattle, WA 98109, USA., Randolph TW; Clinical Research Division, FHCC, Seattle, WA 98109, USA; Public Health Sciences Division, FHCC, WA 98109, USA., Markey KA; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center (FHCC), Seattle, WA 98109, USA; Department of Medicine, University of Washington, Seattle, WA 98109, USA; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Weill Cornell Medical College, New York, NY 10065, USA., Fredricks DN; Vaccine and Infectious Disease Division, FHCC, Seattle, WA 98109, USA; Department of Medicine, University of Washington, Seattle, WA 98109, USA., Hill GR; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center (FHCC), Seattle, WA 98109, USA; Department of Medicine, University of Washington, Seattle, WA 98109, USA. Electronic address: grhill@fredhutch.org.

Publikováno v: Immunity [Immunity] 2023 Aug 08; Vol. 56 (8), pp. 1876-1893.e8. Date of Electronic Publication: 2023 Jul 21.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.